Clinical Trials Browser

Pain, Intractable × Clear all

NCT00804154 2026-03-18

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

Phase 1 Recruiting

Cancer Pain, Pain, Intractable

NCT07400055 2026-02-10

CORD-MRI

Not yet recruiting

Cancer Pain, Neuralgia, Pain, Intractable

NCT06940570 2025-10-23

MATCH

Phase 3 Suspended

Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT01567345 2024-08-02

PITAC

Phase NA Completed

Agnosia, Neoplasms, Pain, Pain, Intractable

NCT05067257 2024-03-18

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Phase 2 Suspended

Cancer Pain, Pain, Pain, Intractable

NCT01854229 2023-10-18

Prometra Post-Approval Study

Phase NA Completed

Cancer Pain, Back Pain, Pain, Intractable, Chronic Pain

NCT00996983 2023-03-24

ZIDON

Phase 2 Unknown

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT02069067 2023-03-24

Break-1

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT02484937 2022-06-29

Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts

Phase NA Terminated

Agnosia, Back Pain, Pain, Intractable, Chronic Pain

NCT04096391 2022-05-18

Prosper-001

Phase NA Completed

Pain, Intractable, Chronic Pain

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

NCT00381095 2021-01-20

COPE

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT03886753 2020-07-30

Ilera

Classical hematology

Autism Spectrum Disorder, Acquired Immunodeficiency Syndrome, Anemia, Sickle Cell, Epilepsy, Glaucoma, Huntington Disease, Multiple Sclerosis, Muscle Spasticity, Neoplasms, Pain, Intractable, Parkinson Disease, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Dyskinesias

NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

Phase NA Unknown

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

NCT03887494 2019-09-10

WAZA-ARY

Phase NA Unknown

Hip Fractures, Pain, Intractable, Neoplasms, Bone Tissue

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Phase 2/3 Completed

Neoplasm Metastasis, Pain, Intractable

NCT02036281 2018-05-15

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Phase 1 Completed

Pain, Intractable

NCT01951911 2017-07-11

KETA-1

Phase 3 Withdrawn

Agnosia, Pain, Intractable

NCT02687347 2016-09-20

UDOME

Phase 3 Unknown

Pain, Intractable

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

NCT01291901 2014-08-08

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Phase 2 Completed

Neoplasms, Pain, Pain, Intractable

NCT01326325 2013-08-07

KEPAL

Phase 3 Completed

Neoplasms, Pain, Pain, Intractable

NCT00484484 2011-05-04

KETADOL

Phase 3 Completed

Neoplasms, Pain, Pain, Intractable

NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Phase 2 Completed

Cancer Pain, Pain, Intractable